タウ・タンパクとは? わかりやすく解説

Weblio 辞書 > 辞書・百科事典 > 百科事典 > タウ・タンパクの意味・解説 

タウタンパク質

(タウ・タンパク から転送)

出典: フリー百科事典『ウィキペディア(Wikipedia)』 (2022/09/16 16:14 UTC 版)

タウタンパク質(タウタンパクしつ、: Tau protein)は、微小管を安定化するタンパク質である。ギリシャ文字τ(タウ)を用いて、τタンパク質と表記されることもある。タウタンパク質は中枢神経系神経細胞に豊富に存在するが、他の部位では一般的ではない。中枢神経系のアストロサイトオリゴデンドロサイトでも極めて低レベルで発現している[5]アルツハイマー病パーキンソン病[6]のような神経系の病理や認知症は、適切な微小管安定化能を失ったタウタンパク質と関係している。


  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000186868、ENSG00000276155、ENSG00000277956 - Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000018411 - Ensembl, May 2017
  3. ^ Human PubMed Reference:
  4. ^ Mouse PubMed Reference:
  5. ^ Shin RW, Iwaki T, Kitamoto T, Tateishi J (May 1991). “Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues”. Laboratory Investigation; A Journal of Technical Methods and Pathology 64 (5): 693–702. PMID 1903170. 
  6. ^ Lei P, Ayton S, Finkelstein DI, Adlard PA, Masters CL, Bush AI (November 2010). “Tau protein: relevance to Parkinson's disease”. Int. J. Biochem. Cell Biol. 42 (11): 1775–8. doi:10.1016/j.biocel.2010.07.016. PMID 20678581. 
  7. ^ Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A (June 1988). “Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau”. Proceedings of the National Academy of Sciences of the United States of America 85 (11): 4051–5. doi:10.1073/pnas.85.11.4051. PMC 280359. PMID 3131773. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC280359/. 
  8. ^ Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (October 1989). “Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease”. Neuron 3 (4): 519–26. doi:10.1016/0896-6273(89)90210-9. PMID 2484340. 
  9. ^ Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (May 1975). “A protein factor essential for microtubule assembly”. Proceedings of the National Academy of Sciences of the United States of America 72 (5): 1858–62. doi:10.1073/pnas.72.5.1858. PMC 432646. PMID 1057175. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC432646/. 
  10. ^ a b c Cleveland DW, Hwo SY, Kirschner MW (October 1977). “Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin”. Journal of Molecular Biology 116 (2): 207–25. doi:10.1016/0022-2836(77)90213-3. PMID 599557. 
  11. ^ Cleveland DW, Hwo SY, Kirschner MW (October 1977). “Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly”. Journal of Molecular Biology 116 (2): 227–47. doi:10.1016/0022-2836(77)90214-5. PMID 146092. 
  12. ^ Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, Hirokawa N (June 1994). “Altered microtubule organization in small-calibre axons of mice lacking tau protein”. Nature 369 (6480): 488–91. doi:10.1038/369488a0. PMID 8202139. 
  13. ^ Dehmelt L, Halpain S (2004). “The MAP2/Tau family of microtubule-associated proteins”. Genome Biology 6 (1): 204. doi:10.1186/gb-2004-6-1-204. PMC 549057. PMID 15642108. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549057/. 
  14. ^ Neve RL, Harris P, Kosik KS, Kurnit DM, Donlon TA (December 1986). “Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2”. Brain Research 387 (3): 271–80. PMID 3103857. 
  15. ^ Sergeant N, Delacourte A, Buée L (January 2005). “Tau protein as a differential biomarker of tauopathies”. Biochimica et Biophysica Acta 1739 (2–3): 179–97. doi:10.1016/j.bbadis.2004.06.020. PMID 15615637. 
  16. ^ Shaw-Smith C, Pittman AM, Willatt L, Martin H, Rickman L, Gribble S, Curley R, Cumming S, Dunn C, Kalaitzopoulos D, Porter K, Prigmore E, Krepischi-Santos AC, Varela MC, Koiffmann CP, Lees AJ, Rosenberg C, Firth HV, de Silva R, Carter NP (September 2006). “Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability”. Nature Genetics 38 (9): 1032–7. doi:10.1038/ng1858. PMID 16906163. 
  17. ^ Zody MC, Jiang Z, Fung HC, Antonacci F, Hillier LW, Cardone MF, Graves TA, Kidd JM, Cheng Z, Abouelleil A, Chen L, Wallis J, Glasscock J, Wilson RK, Reily AD, Duckworth J, Ventura M, Hardy J, Warren WC, Eichler EE (September 2008). “Evolutionary toggling of the MAPT 17q21.31 inversion region”. Nature Genetics 40 (9): 1076–83. doi:10.1038/ng.193. PMC 2684794. PMID 19165922. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684794/. 
  18. ^ Almos PZ, Horváth S, Czibula A, Raskó I, Sipos B, Bihari P, Béres J, Juhász A, Janka Z, Kálmán J (November 2008). “H1 tau haplotype-related genomic variation at 17q21.3 as an Asian heritage of the European Gypsy population”. Heredity 101 (5): 416–9. doi:10.1038/hdy.2008.70. PMID 18648385. 
  19. ^ Hardy J, Pittman A, Myers A, Gwinn-Hardy K, Fung HC, de Silva R, Hutton M, Duckworth J (August 2005). “Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens”. Biochemical Society Transactions 33 (Pt 4): 582–5. doi:10.1042/BST0330582. PMID 16042549. 
  20. ^ Billingsley ML, Kincaid RL (May 1997). “Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration”. The Biochemical Journal 323 ( Pt 3) (3): 577–91. PMC 1218358. PMID 9169588. http://www.biochemj.org/bj/323/0577/bj3230577.htm. 
  21. ^ Taniguchi T, Kawamata T, Mukai H, Hasegawa H, Isagawa T, Yasuda M, Hashimoto T, Terashima A, Nakai M, Mori H, Ono Y, Tanaka C (March 2001). “Phosphorylation of tau is regulated by PKN”. The Journal of Biological Chemistry 276 (13): 10025–31. doi:10.1074/jbc.M007427200. PMID 11104762. 
  22. ^ Kanemaru K, Takio K, Miura R, Titani K, Ihara Y (May 1992). “Fetal-type phosphorylation of the tau in paired helical filaments”. Journal of Neurochemistry 58 (5): 1667–75. doi:10.1111/j.1471-4159.1992.tb10039.x. PMID 1560225. 
  23. ^ Mawal-Dewan M, Henley J, Van de Voorde A, Trojanowski JQ, Lee VM (December 1994). “The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases”. The Journal of Biological Chemistry 269 (49): 30981–7. PMID 7983034. 
  24. ^ Matsuo ES, Shin RW, Billingsley ML, Van deVoorde A, O'Connor M, Trojanowski JQ, Lee VM (October 1994). “Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau”. Neuron 13 (4): 989–1002. doi:10.1016/0896-6273(94)90264-X. PMID 7946342. 
  25. ^ Alonso AD, Grundke-Iqbal I, Barra HS, Iqbal K (January 1997). “Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau”. Proceedings of the National Academy of Sciences of the United States of America 94 (1): 298–303. doi:10.1073/pnas.94.1.298. PMC 19321. PMID 8990203. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC19321/. 
  26. ^ Frost B, Jacks RL, Diamond MI (May 2009). “Propagation of tau misfolding from the outside to the inside of a cell”. The Journal of Biological Chemistry 284 (19): 12845–52. doi:10.1074/jbc.M808759200. PMC 2676015. PMID 19282288. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676015/. 
  27. ^ Calafate S, Buist A, Miskiewicz K, Vijayan V, Daneels G, de Strooper B, de Wit J, Verstreken P, Moechars D (May 2015). “Synaptic Contacts Enhance Cell-to-Cell Tau Pathology Propagation”. Cell Reports 11 (8): 1176–83. doi:10.1016/j.celrep.2015.04.043. PMID 25981034. 
  28. ^ Roman AY, Devred F, Byrne D, La Rocca R, Ninkina NN, Peyrot V, Tsvetkov PO (December 2018). “Zinc Induces Temperature-Dependent Reversible Self-Assembly of Tau”. Journal of Molecular Biology 431 (4): 687–695. doi:10.1016/j.jmb.2018.12.008. PMID 30580037. 
  29. ^ Fichou Y, Al-Hilaly YK, Devred F, Smet-Nocca C, Tsvetkov PO, Verelst J, Winderickx J, Geukens N, Vanmechelen E, Perrotin A, Serpell L, Hanseeuw BJ, Medina M, Buée L, Landrieu I (March 2019). “The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?”. Acta Neuropathologica Communications 7 (1): 31. doi:10.1186/s40478-019-0682-x. PMID 30823892. 
  30. ^ Goedert M, Eisenberg DS, Crowther RA (July 2017). “Propagation of Tau Aggregates and Neurodegeneration”. Annual Review of Neuroscience 40 (1): 189–210. doi:10.1146/annurev-neuro-072116-031153. PMID 28772101. 
  31. ^ Yamada K (2017). “Extracellular Tau and Its Potential Role in the Propagation of Tau Pathology” (English). Frontiers in Neuroscience 11: 667. doi:10.3389/fnins.2017.00667. PMC 5712583. PMID 29238289. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712583/. 
  32. ^ Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, Wolozin B, Butovsky O, Kügler S, Ikezu T (November 2015). “Depletion of microglia and inhibition of exosome synthesis halt tau propagation”. Nature Neuroscience 18 (11): 1584–93. doi:10.1038/nn.4132. PMC 4694577. PMID 26436904. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694577/. 
  33. ^ Nishimura I, Yang Y, Lu B (March 2004). “PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila”. Cell 116 (5): 671–82. doi:10.1016/S0092-8674(04)00170-9. PMID 15006350. 
  34. ^ Chatterjee S, Sang TK, Lawless GM, Jackson GR (January 2009). “Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model”. Human Molecular Genetics 18 (1): 164–77. doi:10.1093/hmg/ddn326. PMC 2644648. PMID 18930955. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644648/. 
  35. ^ Lee HG, Perry G, Moreira PI, Garrett MR, Liu Q, Zhu X, Takeda A, Nunomura A, Smith MA (April 2005). “Tau phosphorylation in Alzheimer's disease: pathogen or protector?”. Trends in Molecular Medicine 11 (4): 164–9. doi:10.1016/j.molmed.2005.02.008. PMID 15823754. 
  36. ^ Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K (June 2001). “Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments”. Proceedings of the National Academy of Sciences of the United States of America 98 (12): 6923–8. doi:10.1073/pnas.121119298. PMC 34454. PMID 11381127. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC34454/. 
  37. ^ Inside the Brain - A tour of how the mind works - Part 2:Alzheimer's Effect”. 2019年4月7日閲覧。
  38. ^ Hall, G.F. (2011) Tau misprocessing leads to non-classical tau secretion via vesicle release – implications for the spreading of tau lesions in AD Int Conf. Alz Dis. meeting Paris, France
  39. ^ Saman, S. and Hall, G. F. (2011) Tau secretion from M1C human neuroblastoma cells occurs via the release of exosomes. Keystone Meeting on Neurodegenerative diseases, Feb 2011, Taos NM
  40. ^ Köglsberger S, Cordero-Maldonado ML, Antony P, Forster JI, Garcia P, Buttini M, Crawford A, Glaab E (December 2017). “Gender-Specific Expression of Ubiquitin-Specific Peptidase 9 Modulates Tau Expression and Phosphorylation: Possible Implications for Tauopathies”. Molecular Neurobiology 54 (10): 7979–7993. doi:10.1007/s12035-016-0299-z. PMC 5684262. PMID 27878758. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684262/. 
  41. ^ Hall GF, Patuto BA (July 2012). “Is tau ready for admission to the prion club?”. Prion 6 (3): 223–33. doi:10.4161/pri.19912. PMC 3399531. PMID 22561167. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399531/. 
  42. ^ Brain Trauma — NOVA | PBS”. www.pbs.org. 2019年4月8日閲覧。
  43. ^ Omalu BI, DeKosky ST, Minster RL, Kamboh MI, Hamilton RL, Wecht CH (July 2005). “Chronic traumatic encephalopathy in a National Football League player”. Neurosurgery 57 (1): 128–34; discussion 128–34. doi:10.1227/01.NEU.0000163407.92769.ED. PMID 15987548. 
  44. ^ Goldstein LE, Fisher AM, Tagge CA, Zhang XL, Velisek L, Sullivan JA, Upreti C, Kracht JM, Ericsson M, Wojnarowicz MW, Goletiani CJ, Maglakelidze GM, Casey N, Moncaster JA, Minaeva O, Moir RD, Nowinski CJ, Stern RA, Cantu RC, Geiling J, Blusztajn JK, Wolozin BL, Ikezu T, Stein TD, Budson AE, Kowall NW, Chargin D, Sharon A, Saman S, Hall GF, Moss WC, Cleveland RO, Tanzi RE, Stanton PK, McKee AC (May 2012). “Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model”. Science Translational Medicine 4 (134): 134ra60. doi:10.1126/scitranslmed.3003716. PMC 3739428. PMID 22593173. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739428/. 
  45. ^ McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, Daneshvar DH, Lee HS, Wojtowicz SM, Hall G, Baugh CM, Riley DO, Kubilus CA, Cormier KA, Jacobs MA, Martin BR, Abraham CR, Ikezu T, Reichard RR, Wolozin BL, Budson AE, Goldstein LE, Kowall NW, Cantu RC (January 2013). “The spectrum of disease in chronic traumatic encephalopathy”. Brain 136 (Pt 1): 43–64. doi:10.1093/brain/aws307. PMC 3624697. PMID 23208308. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624697/. 
  46. ^ Magnoni S, Esparza TJ, Conte V, Carbonara M, Carrabba G, Holtzman DM, Zipfel GJ, Stocchetti N, Brody DL (April 2012). “Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury”. Brain 135 (Pt 4): 1268–80. doi:10.1093/brain/awr286. PMC 3326246. PMID 22116192. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326246/. Lay summary – Washington University in St. Louis. 
  47. ^ Mohandas, E.; Rajmohan, V.; Raghunath, B. (2009-1). “Neurobiology of Alzheimer's disease”. Indian Journal of Psychiatry 51 (1): 55–61. doi:10.4103/0019-5545.44908. ISSN 0019-5545. PMC PMCPMC2738403. PMID 19742193. https://www.ncbi.nlm.nih.gov/pubmed/19742193. 
  48. ^ Augustinack JC, Schneider A, Mandelkow EM, Hyman BT (January 2002). “Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease”. Acta Neuropathologica 103 (1): 26–35. doi:10.1007/s004010100423. PMID 11837744. 
  49. ^ van Slegtenhorst M, Lewis J, Hutton M (July 2000). “The molecular genetics of the tauopathies”. Experimental Gerontology 35 (4): 461–71. doi:10.1016/S0531-5565(00)00114-5. PMID 10959034. 
  50. ^ Treatment Horizon | Alzheimer's Association”. 2019年4月9日閲覧。
  51. ^ Jensen PH, Hager H, Nielsen MS, Hojrup P, Gliemann J, Jakes R (September 1999). “alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356”. The Journal of Biological Chemistry 274 (36): 25481–9. doi:10.1074/jbc.274.36.25481. PMID 10464279. 
  52. ^ Giasson BI, Lee VM, Trojanowski JQ (2003). “Interactions of amyloidogenic proteins”. Neuromolecular Medicine 4 (1–2): 49–58. doi:10.1385/NMM:4:1-2:49. PMID 14528052. 
  53. ^ Klein C, Kramer EM, Cardine AM, Schraven B, Brandt R, Trotter J (February 2002). “Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau”. The Journal of Neuroscience 22 (3): 698–707. doi:10.1523/JNEUROSCI.22-03-00698.2002. PMID 11826099. 
  54. ^ Yu WH, Fraser PE (April 2001). “S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease”. The Journal of Neuroscience 21 (7): 2240–6. doi:10.1523/JNEUROSCI.21-07-02240.2001. PMID 11264299. 
  55. ^ Baudier J, Cole RD (April 1988). “Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II”. The Journal of Biological Chemistry 263 (12): 5876–83. PMID 2833519. 
  56. ^ Hashiguchi M, Sobue K, Paudel HK (August 2000). “14-3-3zeta is an effector of tau protein phosphorylation”. The Journal of Biological Chemistry 275 (33): 25247–54. doi:10.1074/jbc.M003738200. PMID 10840038. 





英和和英テキスト翻訳>> Weblio翻訳
英語⇒日本語日本語⇒英語
  

辞書ショートカット

すべての辞書の索引

タウ・タンパクのお隣キーワード
検索ランキング

   

英語⇒日本語
日本語⇒英語
   



タウ・タンパクのページの著作権
Weblio 辞書 情報提供元は 参加元一覧 にて確認できます。

   
ウィキペディアウィキペディア
All text is available under the terms of the GNU Free Documentation License.
この記事は、ウィキペディアのタウタンパク質 (改訂履歴)の記事を複製、再配布したものにあたり、GNU Free Documentation Licenseというライセンスの下で提供されています。 Weblio辞書に掲載されているウィキペディアの記事も、全てGNU Free Documentation Licenseの元に提供されております。

©2024 GRAS Group, Inc.RSS